Elevance Health (ELV) Shares Outstanding (2009 - 2026)

Elevance Health (ELV) has reported Shares Outstanding (Entity) for 18 consecutive years, with $216.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) fell 3.56% year-over-year to $216.8 million in Q2 2026; TTM through Jun 2026 was $216.8 million, a 3.56% decrease from a year earlier, with the FY2025 full-year figure at $220.7 million, down 2.97% from the prior year.
• Shares Outstanding (Entity) was $216.8 million for Q2 2026 at Elevance Health, roughly flat from $217.4 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $241.1 million in Q1 2022 and troughed at $216.8 million in Q2 2026.
• A 5-year average of $230.6 million and a median of $232.2 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) fell 1.27% in 2024 and declined 4.27% in 2025, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $238.0 million in 2022, then retreated by 2.05% to $233.1 million in 2023, then retreated by 2.4% to $227.5 million in 2024, then slipped by 2.97% to $220.7 million in 2025, then declined by 1.76% to $216.8 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $216.8 million (Q2 2026), $217.4 million (Q1 2026), and $220.7 million (Q4 2025), per Business Quant data.